Daktronics Announces Intention to Convert $25 Million Convertible Promissory Note into Common Stock
Company Intends to Execute Share Repurchases to Offset DilutionBROOKINGS, S.D., Nov. 08, 2024 (GLOBE NEWSWIRE) -- ...
manilatimes6d
Humacyte Third Quarter 2024 Financial Results and Business Update
DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Business Insider6d
Daktronics intends to convert $25M convertible promissory note into common stock
Daktronics (DAKT) announced that, after careful deliberation, the Board of Directors has determined that it is in the best interests of the Company and its common shareholders to exercise the ...